Over 1650 Total Lots Up For Auction at Five Locations - NJ Cleansweep 05/07, NJ Cleansweep 05/08, CA 05/09, CO 05/12, PA 05/15

Biotronik Announces First Lumax 540 Implants

by Jean B. Grillo, Reporter | April 22, 2008
Lumax 540 implantable
cardioverter defibrillator
Patients in 11 hospitals in seven countries are participating in Biotronik's first implants of its Lumax 540 cardiac devices meant to pioneer wireless monitoring technology via long-lasting, battery-powered devices.

The German-based company announced the 540 platform as part of its advanced tachycardia product portfolio of extended care options for individualized remote patient home care monitoring. The device is approved in Europe.

The new Lumax cardioverter defibrillator (ICD) and the cardiac resynchronization defibrillator (CRT-D) identify clinically relevant atrial fibrillation and early detection of worsening heart failure and transmits that information to physicians for immediate response.
stats Advertisement
DOTmed text ad

Training and education based on your needs

Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money

stats
As an industry leader in battery and engineering research, Biotronik achieved longevity for the Lumax 540 platform by extending the life of these devices for up to 10 years.

"Patients benefit from this extended battery longevity, needing fewer device replacements over time, improving quality of life and at the same time helping to reduce health care costs," notes Marlou Janssen, VP of Global Marketing and Sales, Cardiac Rhythm Management.

"In fact," she adds, "we are so confident in the advantages of our new battery technology, we will further extend our warranty for the Lumax 540 ICDs."

The increasing number of implanted cardiac devices and the need for technologies which ease complex programming and enable remote monitoring are among the reasons simplified patient cardiac follow-up has become increasingly important.

In combination with Biotronik Home Monitoring technology, the new Lumax 540 platform allows for continuous automatic daily transmissions of a patient's cardiovascular status to physicians anywhere in the world using an antenna integrated in the Lumax devices and linked to its mobile telephone network.

Biotronik was founded in 1963 when it developed the first German pacemaker. Over the years, its R&D work has produced numerous innovations considered to be milestones in pacemaker technology.